A research study of a new medicine, NNC9733-0001, in healthy participants and participants with type 2 diabetes
NN9733-8133
Phase 1 other active
Quick answer
A research study of a new medicine, NNC9733-0001, in healthy participants and participants with type 2 diabetes for Healthy Participants and Participants with type 2 diabetes is a Phase 1 program (other) at Novo Nordisk A/S with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Novo Nordisk A/S
- Indication
- Healthy Participants and Participants with type 2 diabetes
- Phase
- Phase 1
- Modality
- other
- Status
- active